首页 | 本学科首页   官方微博 | 高级检索  
     

2430例成大及维尔博狂犬疫苗临床安全性观察
引用本文:曹庆,;黄桂花,;闻书英,;潘淮,;章达明. 2430例成大及维尔博狂犬疫苗临床安全性观察[J]. 广东寄生虫学会年报, 2007, 0(7): 693-694
作者姓名:曹庆,  黄桂花,  闻书英,  潘淮,  章达明
作者单位:[1]广州市疾病预防控制中心,广州510080
摘    要:目的评价国产狂犬疫苗和进口狂犬疫苗的安全性,为临床选择安全有效的狂犬疫苗提供依据。方法对2430例国产及进口狂犬疫苗暴露后免疫者,按程序接种后,观察局部和全身反应。结果所有接种对象均未出现严重局部和全身副反应。国产狂犬疫苗副反应发生率为18.1%,进口疫苗副反应发生率为14.6%,二者比较,差异无统计学意义(P〉0.05)。结论两种狂犬疫苗均具有良好的安全性。

关 键 词:狂犬疫苗  安全性

A Safety Study of VERORAB and CDBIO Rabies Vaccines
Affiliation:CAO Qing, HUANG Gui-hua, WEN Shu-ying, PAN Huai, ZHANG Da-ming ( Guangzhou Center for Disease Control and Prevention, Guangzhou 510080, China)
Abstract:Objective To evaluate the safety and efficacy of VERORAB and CDBIO rabies vaccines. Methods 2 430 rabies victims were included in this study. Results None of the vaccinee developed serious reaction after vaccination. The percentage of subjects having side effects after vaccination with VEROR and CDBIO was 18.1% and 14.6%, respectively. The difference is not significant. Conclusion Both VERORAB and CDBIO vaccines are clinically safe for vaccination.
Keywords:rabies vaccines  clinical safety
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号